High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer
- 1 April 1993
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (4) , 825-829
- https://doi.org/10.1038/bjc.1993.151
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of lifeEuropean Journal Of Cancer, 1992
- Weekly dose adriamycin as first line chemotherapy in advanced breast cancer.1991
- In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patientsBritish Journal of Cancer, 1988
- Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerBritish Journal of Cancer, 1987
- A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinomaBritish Journal of Cancer, 1987
- A phase I-II study of intensive-dose adriamycin for advanced breast cancer.Journal of Clinical Oncology, 1987
- Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trialEuropean Journal of Cancer and Clinical Oncology, 1986
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986
- Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Intermediate dose single agent cyclophosphamide chemotherapy of advanced breast cancer.1983